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Abstract Binding of [26,27-3H]25-hydroxycholesterol (25HC)
to human hepatoma Hep G2 cells was saturated within 120 min.
Two intracellular pools of 25HC were identified in a pulse-chase
experiment: (i) an exchangeable pool which was in dynamic
equilibrium with 25HC in the medium (t1=2 of reversible
exchange 15 min) and (ii) an unexchangeable pool which
remained in cells during incubation in medium containing LPDS.
25HC from the exchangeable pool inhibits cholesterol biosyn-
thesis, decreases the HMG CoA reductase mRNA level and
stimulates cholesterol acylation. 25HC from the unexchangeable
pool was partially bound to cytosolic proteins and apparently
utilized for metabolic transformation. Incubation of Hep G2 cells
with [26,27-3H]25HC in the presence of a 30-fold molar excess
of 3L-hydroxy-5K-cholest-8(14)-en-15-one was found to cause (i)
2-fold decrease in the binding of [26,27-3H]25HC to cytosolic
proteins (sedimentation constant of radioactive complex was 4^5
S) and (ii) the 35% inhibition of 25HC transformation to polar
metabolites.
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1. Introduction
Side chain oxygenated sterols are known to have a broad
spectrum of biological activity in vivo and in cultured mam-
malian cells [1^4]. Endogenous 25-hydroxycholesterol (25HC)
either synthesized in cell via the isoprenoid pathway [5] or
formed in liver cells through oxidation of dietary cholesterol
[6,7] regulates cellular cholesterol homeostasis by transcrip-
tional control of sterol sensitive genes and stimulation of
ACAT activity [8^14]. Exogenous 25HC added to cultured
cells decreases the level of HMG CoA reductase and LDL
receptor mRNAs, inhibits cholesterol biosynthesis, stimulates
sterol esteri¢cation, a¡ects the biosynthesis of triacylglycerols
and phospholipids, modi¢es the cellular membrane structure,
suppresses the biosynthesis of protein and DNA, inhibits cell
growth, causes apoptosis and cell damage [11^26].
Biological e¡ects of exogenous 25HC and other oxysterols
in cultured cells have been generally characterized only in
terms of their concentrations in culture medium. However,
studies of localization and tra⁄c oxysterols in cultured cells
are also important. These studies are necessary for the under-
standing of biological activity of oxysterols at the molecular
level and for elucidation of cellular mechanisms underlying
oxysterols inactivation and removal.
The binding of 25HC to cultured cells was shown to be
rapid and saturable [27^31]. Metabolic transformation of
25HC depends on the cell type. In liver cells 25HC is trans-
formed to normal bile acids [2,7,15,32] and undergoes ACAT-
dependent 3-acylation with fatty acid residues [28]. Substan-
tial 3-acylation of 25HC was found in peritoneal macrophages
[27]. Slow 7K-hydroxylation of 25HC by the enzyme di¡ering
from liver 7K-hydroxylase was shown in human ¢broblasts
[33,34]. Transformation of 25HC to pregnenolon was demon-
strated in mouse L ¢broblasts [35].
Substantial proportion of exogenous 25HC in cultured cells
was found in membranes, oxysterol being able to dissociate
into media containing suitable acceptors [19,27]. The unidirec-
tional £ux of 25HC from plasma membrane to the membrane
of endoplasmic reticulum in FuA5 rat hepatoma cells was
found to be 2000 faster than the £ux of cholesterol under
the same conditions [28]. The binding of 25HC to the speci¢c
cytosol protein(s) OSBP was demonstrated in various cell
types [11,29^31,36], however the role of OSBP in sterol me-
tabolism and transport is not well established.
The present work was undertaken to study the tra⁄c of
exogenous 25HC in human hepatoma Hep G2 cells, the cel-
lular model mostly utilized for the investigation of lipid me-
tabolism in the human liver [37]. We demonstrate that the
distribution of radiolabeled 25HC within Hep G2 cells can
be represented in terms of two pools of 25HC di¡ering in
the respect of their exchange with 25HC in the media. The
exchangeable pool of exogenous 25HC in Hep G2 is suggested
to play the principal role in the regulation of sterol metabo-
lism, while the unexchangeable pool is utilized for its meta-
bolic transformations. The role of cytosolic proteins as spe-
ci¢c carriers associated with transformation oxysterols to
polar metabolites is discussed.
2. Materials and methods
25-Hydroxycholesterol, EDTA, Tris-(hydroxymethylamino)meth-
ane (Tris), ATP, glycylglycine, dithiothreitol and PBS were purchased
from Sigma, Triton X-100 from Serva, oleic acid and organic sol-
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vents: chloroform, hexane, methanol, ethanol, 2-propanol, toluene,
ethyl acetate and acetic acid (HPLC grade) from Merck, [26,27-
3H]25-hydroxycholesterol from New England Nuclear (NEN Re-
search Products, Du Pont), [1-14C]acetic acid and [1-14C]oleic acid
from Amersham. FCS, OptiMEM and F12 media were obtained
from Gibco BRL, glutamin from ‘ICN Biomedicals’, culture plastics
from Costar.
LPDS (ds 1.23 g/ml) was isolated from blood plasma of a healthy
volunteer as described [38], followed by heating for 10 min at 60‡C
(for LCAT inactivation) and dialysis against PBS. 3L-Hydroxy-5K-
cholest-8(14)-en-15-one (15-ketosterol) was synthesized according to
Wilson et al. [39]. 3L-(9-cis-Octadecenoyloxy)-cholest-5-en-25-ol was
prepared from 25HC according to improved procedure of acylation
[40] and isolated by TLC in 56% yield.
2.1. Hep G2 cells
Hep G2 cells obtained from European Cell Culture Collection
(ECACC, Salisbury) were cultured in OptiMEM-F12 medium (1:1)
with 10% FCS at 37‡C in the atmosphere of 5% CO2. Before the
experiments the cells seeded in 35 mm dishes, or in 24-well plates,
or in 96-well plates were preincubated for 24 h in the same medium
containing 10% LPDS instead of FCS. All experiments were carried
out in the media containing 10% LPDS.
Oxysterols were added to Hep G2 cells in ethanol solution. The
¢nal ethanol concentration in culture medium was 0.4%; in control
incubations the concentration of ethanol was the same.
The toxicity of 25HC and 15-ketosterol for Hep G2 cells was
checked by MST cytotoxicity assay using ‘Promega Cell Titer Kit’
according to the manufacturer’s protocol. There were no cytotoxic
e¡ects of either 25HC at a concentration of 10 WM or 15-ketosterol
at a concentration of 30 WM during 24 h incubation.
2.2. Binding of [3H]25HC to Hep G2 cells
Binding of [3H]25HC to Hep G2 cells was measured after incuba-
tion of cells during indicated time periods with [3H]25HC (6U105
cpm/ml) and non-labeled 25HC at a concentration of 10 WM or
1 WM (pulse); or in the absence of [3H]25HC (chase). Cells were rinsed
with PBS at 4‡C, treated 2U with 0.5 ml solubilising bu¡er [31] con-
taining 1% Triton X-100, 1 mM ATP, 25 mM glycylglycine, 4 mM
EDTA, 15 mM MgSO4, 15 mM KH2PO4, 1 mM dithiothreitol (pH
7.8), then lipids were extracted with chloroform:methanol mixture
(2:1). Chloroform phase was dried under nitrogen, radioactive prod-
ucts were separated by TLC in a toluene-EtOAc (3:2) system in the
presence of non-radioactive 25HC. Radioactive zones were scrapped
o¡ and used for quantitation in liquid scintillator in a ‘Tracor Instru-
ment’ radioactivity counter. All measurements were carried out in
quadruplicates. Aliquots from aqueous phase were used for quantita-
tion of polar radioactive products (PP) and determination of protein
concentration [41].
2.3. Quantitation of radioactive 25HC, 25HCE and PP
Quantitation of radioactive 25HC, 25HCE and PP was performed
in Hep G2 cells preincubated for 14 h with [3H]25HC (106 cpm/ml)
and 25HC (1 WM or 10 WM) either in the absence or in the presence of
30 WM 15-ketosterol. The cells were then incubated for 2 h, 2U2 h
and 3U2 h in 0.5 ml of the medium containing 10% LPDS or in the
same medium containing 30 WM 15-ketosterol. The cells were treated
with solubilising bu¡er as indicated above. Each cellular extract and
each medium sample was separately treated with chloroform:metha-
nol (2:1) mixture. Radioactivity of PP was measured in aqueous
phases; chloroform phases were dried under nitrogen, radioactive
products were analyzed by TLC in a toluene-EtOAc (3:2) system in
the presence of non-radioactive standards: 25HC and 3L-(9-cis-octa-
decenoyloxy)-cholest-5-en-25-ol. Radioactivity was measured as indi-
cated above.
2.4. The rate of cholesterol biosynthesis and cholesteryl esters
biosynthesis
The rate of cholesterol biosynthesis and cholesteryl esters biosyn-
thesis in Hep G2 cells was measured by incorporation of [14C]acetate
in cholesterol and cholesteryl esters [42] and by incorporation of
[14C]oleate in cholesteryl esters [42].
Before addition of [14C]acetate or [14C]oleate, cells were preincu-
bated: (1) in medium containing 10% LPDS for 3 h (control); (2)
in the same medium plus 10 WM 25HC for 3 h; (3) in the same
medium plus 10 WM 25HC for 3 h followed by incubation in medium
without 25HC for 3 h. The incubations were continued for 3 h more
with [14C]acetate (5 WCi/ml) or with [14C]oleate (0.5 WCi/ml) for cell
samples (1) and (3); or with those radioactive compounds plus 10 WM
25HC for cell sample (2).
Cells were rinsed with PBS at 4‡C, lipids were extracted by hexa-
ne:iPrOH (3:2, v/v) and separated by TLC in a hexane:diethyl ether:
acetic acid (85:14:1). Incorporation of radioactivity in cholesterol,
cholesteryl esters, triglycerides and free fatty acids was quantitated
as above and referred to 1 mg of cell protein. All measurements
were carried out in triplicates.
2.5. HMG CoA reductase mRNA
HMG CoA reductase mRNA level was measured in Hep G2 cells
preincubated: (1) in medium containing 10% LPDS for 3 h (control);
(2) in the same medium plus 10 WM 25HC for 3 h; (3) in the same
medium plus 10 WM 25HC for 3 h followed by incubation in medium
without 25HC for 4 h; (4) in the same medium plus 10 WM 25HC for
7 h.
Total RNA from Hep G2 cells was isolated by acid guanidine
isothiocyanate [43]. The quantitative RT-PCR was performed by the
method based on the intraspecies polymorphism [44], using the total
RNA from mouse liver as an internal standard. The mixture of mouse
RNA (1 Wg) and RNA from Hep G2 (1 Wg) was subjected to RT as
described [44]. The following primers were used for PCR ampli¢ca-
tion: 5P-ATAGGTGGCTACAACGCCC-3P (direct), and 5P-ATGT-
TAGTCCTTAAGAACCCAATGC-3P (reverse) corresponding to
244^262 and 706^730 nucleotides of mouse HMG CoA reductase
cDNA sequence. After digestion of PCR products with HinfI restric-
tion endonuclease, the fragments were separated in a 2% agarose gel
and stained with ethidium bromide. Quantitation of each band was
performed using an ‘Alpha Innotech’s’ digital imaging system. The
quantity of HMG CoA reductase mRNA was normalized to L-actin
mRNA content in the same sample.
2.6. Binding of [3H]25HC to cytosolic proteins
Hep G2 cells in 35 mm dishes were incubated for 3 h with 2 ml
medium containing [3H]25HC (1U106 cpm/ml), 1 WM 25HC and 10%
LPDS or in the same medium in the presence of 30 WM 15-ketosterol.
Cytosolic proteins were isolated according to [30] with minor mod-
i¢cations. The cells were rinsed twice with PBS at 4‡C and frozen at
370‡C. Then the cells were scrapped with a rubber policeman, homo-
genized in 0.5 ml of the bu¡er (50 mM Tris, 1 mM EDTA, 1 mM
dithiotreitol, pH 7.4) and centrifuged at 4‡C and 40 000 rpm in a
Beckman L5-55 ultracentrifuge (LP 42 Ti rotor) for 40 min. The
supernatants containing [3H]25HC were applied on a performed
5^20% sucrose gradient. Ultracentrifugation was carried out at 4‡C
and 40 000 rpm in a Beckman L5-55 ultracentrifuge (SW 40 Ti rotor)
for 20 h.
After centrifugation, 0.8 ml fractions were picked up and used for
quantitation of radioactivity and measurement of sucrose concentra-
tion by refractometry. Sedimentation constants of related radioactive
fractions were estimated by comparison with standards (human serum
albumin, S20w 34:3 S and Q-globulin, S
20
w  7:0 S) in an isokinetic su-
crose linear gradient, or calculated by the general method [45] with
reported modi¢cations [46].
3. Results
The rate of 25HC exchange between cultured cells and me-
dium is known to be dependent on the medium composition
and cellular metabolism peculiarities [19,27]. Since all experi-
ments in the present study were carried out in the presence of
10% LPDS, the binding of radiolabeled 25HC to Hep G2 cells
was studied at constant concentrations (1 WM or 10 WM) of
non-labeled 25HC in the medium. Hep G2 cells were relatively
stable in respect to toxic e¡ects of 25HC: a 24 h incubation of
cells with 25HC at a concentration of 10 WM did not cause
cell damage, as demonstrated by MST assay.
The binding of [3H]25HC to Hep G2 cells was studied in a
pulse-chase experiment (Fig. 1). The content of radioactivity
in cells was saturated within 120 min and was higher at 10 WM
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25HC compared with those at 1 WM. Preincubation of Hep
G2 cells for 4 h with non-radioactive 10 WM 25HC a¡ected
neither the rate of binding of radioactivity to cells nor the
content of radioactivity within cells at the saturation. Prein-
cubation of Hep G2 cells with 30 WM 5K-cholest-8(14)-en-15-
on-3L-ol (15-ketosterol, the known synthetic inhibitor of ster-
ol biosynthesis [47]) also did not a¡ect the binding of
[3H]25HC to cells. The binding curves for cells preincubated
with 25HC or with 15-ketosterol were the same as shown in
Fig. 1.
Further incubation of Hep G2 cells prelabeled with
[3H]25HC in medium containing non-radioactive 25HC at
the same concentration (chase) caused the e¥ux of 50^60%
of radioactivity from the cells within 120^150 min, the rate of
binding [3H]25HC being equal to the rate of e¥ux. Substan-
tial part of [3H]25HC (40^50%) remained within the cells. Not
less than 88% of the cell radioactivity during a 6 h period was
found in 25HC fraction. Therefore, [3H]25HC bound to Hep
G2 cells could be divided into two pools which di¡er in re-
spect to the rate of their exchange with 25HC in the media.
The t1=2 value of equilibrium exchange between 25HC in me-
dia and 25HC in exchangeable pool was calculated to be near
15 min.
Exogenous 25HC which belongs to these di¡erent pools
was assumed to have di¡erent e¡ects on sterol metabolism.
To check this assumption we compared the well known e¡ects
of 25HC on the levels of HMG CoA reductase mRNA (Fig.
2A), cholesterol biosynthesis (Fig. 2B) and cholesteryl esters
biosynthesis (Fig. 2C and D) in Hep G2 cells incubated with
10 WM 25HC for 3 h with those if cells were subsequently
chased for 3 h in medium without 25HC. Obviously, 25HC
which belongs to exchangeable pool must e¥ux from the cells
during the chase.
Comparison of Fig. 2A and B shows that both HMG CoA
reductase mRNA level and cholesterol biosynthesis rate are
e¡ectively inhibited by 25HC. These e¡ects occur during a 3 h
incubation. There were no signi¢cant di¡erences depending on
the incubation of prelabeled cells with LPDS. Incorporation
of [14C]acetate in triacylglycerols, phospholipids and free fatty
acids did not depend on the presence of 25HC in our experi-
ments.
Although the inhibition of HMG CoA reductase activity
decreased the incorporation of [14C]acetate in cholesterol,
the total incorporation of radioactivity in cholesteryl esters
in the presence of 25HC was increased (2, Fig. 2C). This e¡ect
was evidently due to the stimulation of ACAT activity by
25HC [12,14]. Subsequent incubation of cells in medium with-
out 25HC (chase) abolished this e¡ect (3, Fig. 2C). The rela-
tive rates of cholesteryl esters synthesis from [14C]oleate de-
pended on the incubation of prelabeled cells with LPDS (Fig.
2D). These data indicated that 25HC which belongs to ex-
changeable pool takes the principal part in stimulation of
sterol esteri¢cation.
Prolong incubation of Hep G2 cells with [3H]25HC led to
the appearance of radioactive metabolites. Quantitation of
radioactive products was performed in Hep G2 cells preincu-
bated with [3H]25HC for 14 h. Radioactive products were
analyzed by TLC in a toluene-EtOAc (3:2) system in the
presence of related synthetic standards. Besides 25HC (Rf
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Table 1
The content of radioactive products (%) in prelabeled Hep G2 cells and in medium during incubationa
Time of chase Radioactive compound Content within cells Content in mediumb
0 Total 100 ^
25HC 69( þ 4) ^
25HCE 22( þ 3) ^
PP 4( þ 2) ^
2 Total 71( þ 6) 33( þ 5)
25HC 45( þ 4) 21( þ 3)
25HCE 23( þ 4) 2
PP 6 2 11( þ 5)
4 Total 57( þ 6) 48( þ 6)
25HC 22( þ 4) 33( þ 4)
25HCE 27( þ 7) 3( þ 2)
PP 6 2 14( þ 4)
6 Total 46( þ 5) 56( þ 6)
25HC 18( þ 3) 31( þ 2)
25HCE 24( þ 4) 4( þ 2)
PP 6 2 22( þ 5)
aQuantitation of radioactive products was performed as described in Section 2. The mean values of four independent experiments are given. The
total radioactivity of prelabeled cells in each experiment was assumed as 100%.
bThe content of radioactive products after 4 and 6 h incubation in medium was obtained as a sum of two and three medium samples for each well,
respectively.
Fig. 1. Binding of [3H]25HC to Hep G2 cells at a concentrations of
25HC of 1 WM (1) and 10 WM (2). For details see Section 2. Protein
concentration per well was 0.2 mg. The arrow indicates the start of
chase.
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0.42) a non-polar fraction (Rf 0.78, 25HCE, which comigrated
with synthetic 3L-(9-cis-octadecenoyloxy)-cholest-5-en-25-ol
and gave 25HC under alkali saponi¢cation), and polar prod-
ucts (PP found in aqueous phase), were detected.
Obviously, 25HCE formation was due to ACAT-dependent
25HC acylation, whereas PP formation was due to oxidative
scission of C-17 side chain resulted in the loss of [3H] at C-
26VC-27 [7,15]. There were no attempts to identify polar
25HC metabolites in the present study. Radioactive 7K,25-
dihydroxycholesterol and 7K,25-dihydroxy-cholest-4-en-3-
one, major metabolites of 25HC in human ¢broblasts
[33,34], were not found in substantial quantities in Hep G2
cells.
Subsequent incubation of prelabeled cells in media for 2 h,
2U2 h and 3U2 h led to signi¢cant dissociation of radioactive
products from cells and caused considerable changes in the
distribution of radioactive products between cells and medium
(Table 1). Within 4 h about 60% of [3H]25HC was e¥uxed
from cells to medium, then the rate of e¥ux was signi¢cantly
decreased. PP were found in the culture medium, 25HCE were
mainly stored within the cells. The total content of PP in-
creased during incubation of the cells with LPDS, while the
content of 25HCE in the cells seemed to be constant.
Intracellular binding of 25HC to cytosolic proteins has been
shown in various cells [11,29^31,36]. Several studies [30,31,36]
demonstrated that incubation of radiolabeled 25HC with cul-
tured cells followed by centrifugation of cytosol led to the
formation of the radiolabeled 25HC-OSBP complex. It was
reasonable to suggest that formation of 25HC unexchangeable
pool is caused by interaction of exogenous 25HC with cyto-
solic proteins. Therefore, the presence of some exogenous
sterols (for example 15-ketosterol which possesses high a⁄nity
to OSBP [48]) could a¡ect intracellular binding, transport and
metabolism of 25HC in Hep G2 cells.
Hep G2 cells were preincubated for 14 h with [3H]25HC
followed by incubation in medium for 2 h, 2U2 h and 3U2 h.
The same experiment was performed in the presence of a 30-
fold molar excess of 15-ketosterol. Quantitation of radioactive
compounds (25HC, 25HCE and PP) in the cells and in media
either in the absence or in the presence of 15-ketosterol is
shown in Fig. 3. The content of radioactive 25HC in the cells
in the presence of 15-ketosterol seemed slightly lower than in
control experiment, but the e¡ect was not signi¢cant. The
presence of 15-ketosterol decreased the formation and e¥ux
of PP about 35% during the 6 h chase compared with control.
The labeling of Hep G2 cells with [3H]25HC (either in the
absence or in the presence of 15-ketosterol) was carried out
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Scheme 1.
Fig. 3. Distribution of [3H]25HC and its metabolites in Hep G2
cells and in culture medium. Hep G2 cells were preincubated for 14
h with [3H]25HC (106 cpm/ml plus 1 WM 25HC) followed by chase
with medium containing 10% LPDS (1), the same experiment in the
presence of 30 WM 15-ketosterol (2). A: Content of [3H]25HC with-
in cells during chase. B: Content of [3H]25HC secreted into me-
dium. C: Content of radiolabeled 25HCE within cells. D: Content
of radiolabeled PP secreted into medium. Protein concentration per
well was 0.2 mg.
Fig. 2. HMG CoA reductase mRNA level (A); cholesterol biosyn-
thesis level from [14C]acetate (B); cholesteryl ester biosynthesis level
from [14C]acetate (C); cholesteryl esters biosynthesis level from
[14C]oleate (D) in control Hep G2 cells (1), cells treated with 10 WM
25HC (2), and the same cells subsequently incubated for 3 h in me-
dium containing 10% LPDS (3). The HMG CoA reductase mRNA
level in cells incubated with 10 WM 25HC for 7 h is shown as A(4).
For details see Section 2. The control values (100%) for cholesterol
synthesis and cholesteryl esters synthesis from [14C]acetate were:
23 600 cpm/mg of cell protein/h and 1900 cpm/mg of cell protein/h,
respectively; the control value for cholesteryl esters synthesis from
[14C]oleate was 2600 cpm/mg of cell protein/h.
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under the conditions reported previously [30] for isolation of
the 25HC-OSPB complex (7.6 S) from human leukemic T-
cells. In our experiments cytosolic fraction contained 12% of
radioactivity bound to cells in the absence and 18% in the
presence of 15-ketosterol. [3H]25HC was found to be the
only radioactive compound in the cytosolic fraction. The pro-
¢le of the ultracentrifugation of radioactive cytosol in a
5^20% sucrose gradient is shown in Fig. 4. [3H]25HC was
found both in fraction 1 (apparently non-bound to proteins)
and in fractions 3^5 with sedimentation coe⁄cient 4^5 S. The
binding of 25HC to cytosolic proteins with the same sedimen-
tation coe⁄cient was shown earlier [49] in mouse ¢broblasts,
the binding of [3H]25HC to fraction 7.6 S in our experiments
was not observed. The presence of 15-ketosterol increased the
total content of [3H]25HC in the cytosol for approximately
50^60% with simultaneous 2-fold decreasing of [3H]25HC
binding to the fraction 4^5 S. These data suggest that part
of [3H]25HC bound to Hep G2 cells exists in a complex with
cytosolic proteins and 15-ketosterol a¡ects the concentration
of this complex.
Taken together, the data shown in Figs. 3 and 4 suggest
that the binding of oxysterols to cytosolic proteins is impor-
tant for transformation of oxysterols to polar metabolites.
4. Discussion
About 20 years ago Kandutch and coworkers put forward a
hypothesis that cholesterol biosynthesis in cells is normally
regulated by endogenously synthesized oxysterols [50]. Intra-
cellular concentration of oxysterols is reduced by incubation
of cells in media containing suitable acceptors for oxysterols
[19,27]. The decrease in the intracellular oxysterol content
caused by incubation of cells in LPDS activates HMG CoA
reductase and LDL receptor with a simultaneous elevation of
the corresponding mRNAs [3,8^11]. On the other hand, the
intracellular binding of oxysterols to speci¢c cytosolic proteins
is well documented [11,29^31,36,48,49].
We have suggested that some information regarding intra-
cellular transport of endogenous oxysterols and their role in
the sterol metabolism regulation could be obtained from stud-
ies of exogenous oxysterol tra⁄c. The results of the present
study demonstrate that exogenous 25HC in Hep G2 cells is
distributed between two pools. A scheme illustrating the traf-
¢c of exogenous 25HC in Hep G2 cells was proposed (Scheme
1).
Exogenous 25HC rapidly and reversibly binds to Hep G2
cells and probably joints the endogenous oxysterols (ex-
changeable pool). 25HC which belongs to this pool does not
bind to OSBP, since neither preincubation with 25HC nor the
excess of 15-ketosterol a¡ects the binding of radiolabeled
25HC to the cells during a short incubation. The exchangeable
pool of 25HC was found to be in dynamic equilibrium with
25HC in the culture medium and to stimulate sterol esteri¢-
cation. Inhibition of cholesterol biosynthesis and HMG CoA
reductase activity by 25HC occurs after a short incubation.
Therefore, we assumed that this exchangeable pool of 25HC
plays the principal role in the regulation of the sterol metab-
olism, interacting with nuclear receptors and mediating the
known cascade regulation of sterol sensitive genes [51^53].
Twelve^eighteen percents of 25HC from unexchangeable
pool was found in cytosol fraction. The presence of 15-keto-
sterol reduces the binding of 25HC to cytosolic proteins with
a simultaneous decrease in the oxidative transformation of
25HC to polar metabolites. Therefore, we have suggested
that the speci¢c cytosolic proteins serve as carriers that par-
ticipate in inactivation and degradation of the oxysterol,
rather than mediate their regulatory e¡ects.
It was reported that resistance of some cell lines to the toxic
e¡ect of 25HC correlates with the intracellular level of OSBP
[30]. (3K,4K,5K)-4-(2-Propenylcholestan-3L-ol) (LY295427)
was found to stimulate the binding of 25HC to OSBP in
CHO-K1 cells and to cause the binding of 25HC to 170
kDa cytosolic protein from hamster liver [31]. Enhanced bind-
ing of 25HC to cytosolic proteins was found to stimulate LDL
receptor activity [54]. Recent studies in transformed CHO-K1
cells, which express a wild-type rabbit OSBP [55], demon-
strated that overexpression of OSBP results in 50% decrease
in the cholesteryl esters synthesis stimulated by 25HC and a
50% elevation of mRNA levels for three sterol sensitive genes
(HMG CoA reductase, HMG CoA synthase and LDL recep-
tor). 15-Ketosterol, which is as e¡ective as 25HC in the ability
to inhibit HMG CoA reductase activity in Hep G2 cells [56],
nevertheless was 10-fold less potent in decreasing the corre-
sponding mRNA level in the same cells [57].
All these data can be explained suggesting that OSBP and
related cytosolic proteins are capable to bind regulatory oxy-
sterols within cells with the formation of inactive complex,
which is utilized for transformation of oxysterols to polar
metabolites. The concentration of this complex as well as
the concentration of free regulatory oxysterols, obviously,
must depend on the presence of other compounds with the
a⁄nity for cytosolic proteins.
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